Impaired Satiety Effect of GLP-1 Agonist in Obesity Is Associated With GLP-1 Resistance in Intestinal Afferent Nerves

被引：0
|
作者：
Al-Helaili, Alaa
Wang, Beini
Beyak, Michael
机构：
来源：
GASTROENTEROLOGY | 2014年 / 146卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Tu1784
引用
收藏
页码：S842 / S842
页数：1
相关论文
共 50 条
  • [31] GLP-1 in NIDDM
    Holst, JJ
    DIABETIC MEDICINE, 1996, 13 (09) : S156 - S160
  • [32] GLP-1 receptor agonists in the treatment of obesity
    Disse, E.
    CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION, 2024, 28 (01): : 18 - 21
  • [33] GLP-1 and the gut
    Thompson, DG
    GUT, 2000, 46 (05) : 591 - 591
  • [34] GLP-1 and GIP analogues in the treatment of obesity
    Jasinska-Balwierz, Agata
    Balwierz, Radoslaw Jerzy
    Biernat, Pawel
    Makieieva, Natalina
    Tomkow, Marek
    Cesarz, Klaudia
    Osowski, Marcin
    Dorozynski, Bartlomiej
    Skotnicka-Graca, Urszula
    Lipok, Jacek
    PEDIATRIA I MEDYCYNA RODZINNA-PAEDIATRICS AND FAMILY MEDICINE, 2024, 20 (02): : 162 - 167
  • [35] What Is GLP-1 Really Doing in Obesity?
    Hira, Tohru
    Pinyo, Jukkrapong
    Hara, Hiroshi
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2020, 31 (02): : 71 - 80
  • [36] GLP-1 physiology informs the pharmacotherapy of obesity
    Drucker, Daniel J.
    MOLECULAR METABOLISM, 2022, 57
  • [37] GLP-1 analogues in obesity: a cautionary tale
    Derrien, Elisa
    ACTUALITES PHARMACEUTIQUES, 2024, 63 (640):
  • [38] Pairing up with GLP-1 to combat obesity
    Crunkhorn, Sarah
    NATURE REVIEWS DRUG DISCOVERY, 2025, 24 (02) : 89 - 89
  • [39] A Role for GLP-1 in Treating Hyperphagia and Obesity
    Grill, Harvey J.
    ENDOCRINOLOGY, 2020, 161 (08)
  • [40] The benefits of GLP-1 drugs beyond obesity
    Drucker, Daniel J.
    SCIENCE, 2024, 385 (6706) : 258 - 260
12345